A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
- PMID: 8674120
- DOI: 10.1016/s0092-8674(00)81314-8
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
Abstract
Here, we show that the beta-chemokine receptor CKR-5 serves as a cofactor for M-tropic HIV viruses. Expression of CKR-5 with CD4 enables nonpermissive cells to form syncytia with cells expressing M-tropic, but not T-tropic, HIV-1 env proteins. Expression of CKR-5 and CD4 enables entry of a M-tropic, but not a T-tropic, virus strain. A dual-tropic primary HIV-1 isolate (89.6) utilizes both Fusin and CKR-5 as entry cofactors. Cells expressing the 89.6 env protein form syncytia with QT6 cells expressing CD4 and either Fusin or CKR-5. The beta-chemokine receptors CKR-3 and CKR-2b support HIV-1 89.6 env-mediated syncytia formation but do not support fusion by any of the T-tropic or M-tropic strains tested. Our results suggest that the T-tropic viruses characteristic of disease progression may evolve from purely M-tropic viruses prevalent early in virus infection through changes in the env protein that enable the virus to use multiple entry cofactors.
Similar articles
-
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.J Virol. 1997 Oct;71(10):7478-87. doi: 10.1128/JVI.71.10.7478-7487.1997. J Virol. 1997. PMID: 9311827 Free PMC article.
-
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.J Virol. 1997 Apr;71(4):3219-27. doi: 10.1128/JVI.71.4.3219-3227.1997. J Virol. 1997. PMID: 9060685 Free PMC article.
-
A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.J Virol. 1996 Sep;70(9):6288-95. doi: 10.1128/JVI.70.9.6288-6295.1996. J Virol. 1996. PMID: 8709256 Free PMC article.
-
Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1).Immunol Res. 1997 Feb;16(1):15-28. doi: 10.1007/BF02786321. Immunol Res. 1997. PMID: 9048206 Review.
-
Chemokine receptors and HIV.J Leukoc Biol. 1997 Jul;62(1):20-9. doi: 10.1002/jlb.62.1.20. J Leukoc Biol. 1997. PMID: 9225988 Review.
Cited by
-
Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.J Virol. 2016 Oct 28;90(22):10065-10073. doi: 10.1128/JVI.01215-16. Print 2016 Nov 15. J Virol. 2016. PMID: 27535053 Free PMC article.
-
When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?J Neuroimmune Pharmacol. 2013 Mar;8(1):118-31. doi: 10.1007/s11481-012-9353-4. Epub 2012 Apr 15. J Neuroimmune Pharmacol. 2013. PMID: 22527632 Free PMC article. Review.
-
HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.Nat Med. 1999 Sep;5(9):997-103. doi: 10.1038/12433. Nat Med. 1999. PMID: 10470075 Free PMC article.
-
An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins.J Virol. 2005 May;79(9):5616-24. doi: 10.1128/JVI.79.9.5616-5624.2005. J Virol. 2005. PMID: 15827176 Free PMC article.
-
HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.J Neurovirol. 2001 Jun;7(3):235-49. doi: 10.1080/13550280152403281. J Neurovirol. 2001. PMID: 11517398
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials